A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis
NCT02242435
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
342
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis of the Knee
Interventions
BIOLOGICAL:
4 mL injection of Ampion
DRUG:
4 mL Injection of Placebo
Sponsor
Ampio Pharmaceuticals. Inc.